" class="no-js "lang="en-US"> Pattern Health Closes $3.3M Series A to Expand Digital Health Research and Clinical Implementation Capabilities - Pharmtech Focus
Friday, January 27, 2023

Pattern Health Closes $3.3M Series A to Expand Digital Health Research and Clinical Implementation Capabilities

Pattern Health, a digital health company, today announced the closing of a $3.3 million series A funding round. The round was led by the Dr. William H. Joyce Family Office, with contributions from existing investors Cofounders CapitalThe Launch Place, and Triangle Tweener FundAllen A. Spizzo of the Joyce Family Office has joined the board of directors.

Pattern will use the new capital to fuel the company’s growth and ability to deliver on its mission–accelerating digital health innovation from research to real-world impact. The company’s unique no-code digital health platform helps partners more quickly and cost-effectively research and develop new ways to improve care and, once proven effective, deliver their innovations at scale to improve more patients’ lives.

“This is an exciting time for Pattern, our partners, and the patients who benefit from the solutions being developed and deployed on our platform,” notes Pattern’s CEO and Co-Founder, Ed Barber. “We are thankful to the academic medical centers, health systems, and leading researchers that have put their trust in Pattern as their digital health innovation partner of choice. Our series A will enable us to more rapidly improve our technology, expand our footprint, and benefit more people at a greater scale.”

Pattern’s capabilities are enabled by a no-code digital health platform that provides the interoperability, scalability, security, and compliance needed to create and distribute digital health programs. The company currently powers research across a wide range of conditional areas at 12 of the top 20 academic medical centers in the US as measured by NIH funding.

“Pattern has made an impressive impact to date, and we are excited by the opportunity to scale the business,” said Mr. Spizzo of the Joyce Family Office. “Pattern’s no-code platform is a game-changer for healthcare researchers and innovators, and the company solves an unmet need by providing a pathway for effective digital health programs to reach patients quickly.”

People In This Post

Companies In This Post

  1. Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Higher-Risk Myelodysplastic Syndrome Read more
  2. Merck Animal Health Receives U.S. FDA Approval of Expanded Indication for BRAVECTO Chews for Dogs Read more
  3. Sharecare Launches VR Program to Improve Well-being of American Workforce Read more
  4. Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer Read more
  5. Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment Read more